What is Pemigatinib: Uses, Dosage, Side Effects and More

Pemigatinib is a targeted cancer medication that blocks specific proteins helping certain cancers grow. It's specifically designed to treat bile duct cancer (cholangiocarcinoma) that has a particular genetic change called an FGFR2 fusion or rearrangement.

This medication belongs to a class of drugs called kinase inhibitors, which work like precision tools targeting cancer cells while trying to spare healthy tissue. Your doctor will only prescribe pemigatinib after confirming your cancer has the specific genetic marker it targets.

What is Pemigatinib Used For?

Pemigatinib treats adults with bile duct cancer that has spread or cannot be removed by surgery. Your cancer must test positive for FGFR2 fusion or rearrangement, which your doctor will confirm through genetic testing of your tumor.

Bile duct cancer is relatively rare, affecting the tubes that carry bile from your liver to your small intestine. This medication offers hope for patients whose cancer has this specific genetic change, giving doctors a targeted treatment option rather than just general chemotherapy.

Your oncologist will typically consider pemigatinib when other treatments haven't worked or aren't suitable for your situation. It's what doctors call a "precision medicine" because it targets the exact genetic problem driving your particular cancer.

How Does Pemigatinib Work?

Pemigatinib blocks proteins called FGFR (fibroblast growth factor receptors) that send growth signals to cancer cells. When these proteins are overactive due to genetic changes, they tell cancer cells to grow and spread rapidly.

Think of FGFR proteins like faulty accelerator pedals in cancer cells that are stuck in the "go" position. Pemigatinib acts like a brake, stopping these signals and slowing down cancer growth.

This is considered a moderately strong targeted therapy. It's more precise than traditional chemotherapy but can still cause significant side effects because FGFR proteins also exist in healthy cells throughout your body.

How Should I Take Pemigatinib?

Take pemigatinib exactly as your doctor prescribes, usually once daily on an empty stomach. You'll need to avoid eating for at least one hour before and two hours after taking your dose.

Swallow the tablets whole with a full glass of water - don't crush, break, or chew them. Taking pemigatinib with food can increase how much your body absorbs, potentially leading to more side effects.

Your doctor will likely start you on a specific dosing schedule that includes planned breaks. This might seem unusual, but these "drug holidays" help your body recover and manage side effects while still fighting your cancer effectively.

Try to take your medication at the same time each day to maintain steady levels in your system. If you need to travel or change your routine, plan ahead to avoid missing doses.

How Long Should I Take Pemigatinib For?

You'll continue taking pemigatinib as long as it's working to control your cancer and the side effects remain manageable. Your doctor will monitor your response through regular scans and blood tests.

Most people take pemigatinib in cycles that include treatment periods followed by planned breaks. A typical cycle might involve taking the medication for 14 days, then having a 7-day rest period.

Your treatment duration depends on how well your cancer responds and how your body tolerates the medication. Some people may take it for months, while others might need it for years.

Never stop taking pemigatinib without discussing it with your oncologist first. Even if you're feeling better, stopping suddenly could allow your cancer to start growing again.

What Are the Side Effects of Pemigatinib?

Pemigatinib can cause side effects because it affects FGFR proteins in both cancer cells and healthy cells throughout your body. Most people experience some side effects, but they're often manageable with proper care.

Here are the most common side effects you might experience while taking pemigatinib:

• Hair loss or thinning, which usually affects all body hair
• Nail changes including brittleness, ridging, or slow growth
• Dry skin and mouth that may require extra moisturizing
• Diarrhea that can range from mild to severe
• Fatigue that may feel more intense than usual tiredness
• Decreased appetite leading to weight loss
• Joint pain or stiffness, particularly in hands and feet

These side effects typically develop within the first few weeks of treatment and often improve as your body adjusts to the medication.

Some less common but more serious side effects require immediate medical attention and include:

• Eye problems including dry eyes, blurred vision, or eye pain
• High phosphate levels in blood, which your doctor monitors through lab tests
• Severe dehydration from persistent diarrhea
• Signs of liver problems like yellowing of skin or eyes
• Kidney function changes detected through blood tests

Your healthcare team will monitor you closely for these more serious effects and adjust your treatment plan if needed.

Rare but serious side effects can include severe skin reactions, heart rhythm changes, or blood clotting problems. While these are uncommon, it's important to report any unusual symptoms to your doctor immediately.

Who Should Not Take Pemigatinib?

Pemigatinib isn't suitable for everyone, and your doctor will carefully review your medical history before prescribing it. You shouldn't take this medication if you're allergic to pemigatinib or any of its ingredients.

Pregnant women should not take pemigatinib as it can harm the developing baby. If you're of childbearing age, you'll need to use effective birth control during treatment and for some time after stopping the medication.

People with severe liver or kidney problems may need dose adjustments or might not be candidates for pemigatinib treatment. Your doctor will run tests to check these organ functions before starting treatment.

If you're breastfeeding, you'll need to discuss the risks and benefits with your doctor, as it's unclear whether pemigatinib passes into breast milk.

Pemigatinib Brand Name

Pemigatinib is sold under the brand name Pemazyre in the United States. This is the only FDA-approved brand currently available for this medication.

Your pharmacy might need to special order Pemazyre since it's a specialized cancer medication. It's typically quite expensive, so discuss insurance coverage and patient assistance programs with your healthcare team.

Pemigatinib Alternatives

Currently, there aren't many direct alternatives to pemigatinib for treating FGFR2-positive bile duct cancer. However, your doctor might consider other FGFR inhibitors or clinical trials if pemigatinib isn't working or causing too many side effects.

Traditional chemotherapy options like gemcitabine plus cisplatin might be used if targeted therapy isn't appropriate for your situation. Immunotherapy drugs are also being studied for bile duct cancer.

Your oncologist will discuss all available options based on your specific cancer type, overall health, and treatment history. Clinical trials might offer access to newer medications still being studied.

Is Pemigatinib Better Than Other FGFR Inhibitors?

Pemigatinib is specifically designed to target FGFR2 fusions in bile duct cancer, making it more selective than some other FGFR inhibitors. This selectivity can mean fewer side effects compared to drugs that block multiple FGFR types.

Compared to other FGFR inhibitors, pemigatinib has shown good effectiveness in clinical trials specifically for bile duct cancer patients. However, each person's cancer is unique, and what works best varies from patient to patient.

Your doctor will choose the best treatment based on your specific genetic test results, overall health, and how well you might tolerate different medications. The "best" drug is the one that works most effectively for your particular situation.